PBM
Psyence Biomedical Ltd. Common Shares
NASDAQ: PBM · HEALTHCARE · BIOTECHNOLOGY
$6.59
+29.72% today
Updated 2026-04-30
Market cap
$16.17M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-389.98
Dividend yield
—
52W range
$2 – $75
Volume
3.0M
WallStSmart proprietary scores
23
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $8.23M | $8.01M | $-51.16M | $1.01M | $-753254.00 |
| EPS | — | — | — | — | $-389.98 |
| Free cash flow | $-1.40M | $-519603.00 | $-2.95M | $-3.74M | — |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Psyence Biomedical Ltd. Common Shares trades at $6.59. Our Smart Value Score of 23/100 indicates the stock is weak.
Frequently asked questions
What is Psyence Biomedical Ltd. Common Shares's stock price?
Psyence Biomedical Ltd. Common Shares (PBM) trades at $6.59.
Is Psyence Biomedical Ltd. Common Shares overvalued?
Smart Value Score 23/100 (Grade F, Strong Sell).
What is the price target of Psyence Biomedical Ltd. Common Shares (PBM)?
The analyst target price is $—, representing NaN% downside from the current price of $6.59.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-74.30%
Beta0.31
50D MA$3.49
200D MA$80.50
Shares out0.00B
Float0.00B
Short ratio—
Avg volume3.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—